Arteriosclerosis and Thrombosis, Vol 11, 1192-1203, Copyright © 1991 by American Heart Association

ARTICLES

Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity

T Pollare, B Vessby and H Lithell
Department of Geriatrics, Uppsala University, Sweden.

The relative effects of obesity, alone or in combination with insulin resistance and hyperinsulinemia (with or without diabetes), on lipoprotein concentrations, blood pressure, and other risk factors for cardiovascular disease were investigated in 28 men (mean age, 63 years). Special attention was given to lipoprotein lipase (LPL) activity in tissues and to postheparin plasma LPL activity and hepatic lipase activity and their relation to insulin resistance. The 28 men fulfilled the entrance criteria of the study so that they could be allocated to one of the four groups (seven in each group): 1) normal body weight, normal fasting insulin level, and normal glucose tolerance (controls); 2) the same as in group 1 but with moderate obesity; 3) the same as in group 2 but with fasting hyperinsulinemia; 4) the same as in group 3 but with non-insulin-dependent diabetes mellitus. Glucose infusion rate for the control group was 8.1 +/- 2.1 mg/kg body wt/min (mean +/- SD) at an insulin infusion rate of 56 milliunits/m2/min. The average values in groups 2, 3, and 4 were 6.0 +/- 0.7, 3.2 +/- 0.5, and 1.9 +/- 1.0 mg/kg body wt/min, respectively. Concentrations of very low density lipoproteins as well as blood pressure and urate concentrations were highest and those of high density lipoproteins were lowest in the two hyperinsulinemic groups (groups 3 and 4). Skeletal muscle LPL activity was 46 +/- 23, 41 +/- 25, 23 +/- 6, and 31 +/- 13 milliunits/g wet wt (mean +/- SD) in the four groups, respectively. There was a positive correlation between glucose infusion rate and muscle LPL activity (r = 0.58, p less than 0.0001). The hepatic lipase activity was positively correlated with the insulin area under the curve of the intravenous glucose tolerance test (r = 0.35, p = 0.02). Furthermore, blood pressure, free fatty acid concentration, liver enzymes, and urate concentrations were significantly correlated with glucose infusion rate at the clamp test. These data give further support for insulin resistance as an important factor behind the observed lipoprotein abnormalities and blood pressure elevations as part of the insulin resistance syndrome characteristic for obese and diabetic patients.

This article has been cited by other articles:

				H. Wang and R. H. Eckel Lipoprotein lipase: from gene to obesity Am J Physiol Endocrinol Metab, August 1, 2009; 297(2): E271 - E288. [Abstract] [Full Text] [PDF]

				E. Ingelsson, J. Arnlov, B. Zethelius, R. S. Vasan, A. Flyvbjerg, J. Frystyk, C. Berne, A. Hanni, L. Lind, and J. Sundstrom Associations of Serum Adiponectin with Skeletal Muscle Morphology and Insulin Sensitivity J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 953 - 957. [Abstract] [Full Text] [PDF]

				E. Nerpin, U. Riserus, E. Ingelsson, J. Sundstrom, M. Jobs, A. Larsson, S. Basu, and J. Arnlov Insulin Sensitivity Measured With Euglycemic Clamp Is Independently Associated With Glomerular Filtration Rate in a Community-Based Cohort Diabetes Care, August 1, 2008; 31(8): 1550 - 1555. [Abstract] [Full Text] [PDF]

				E. Ingelsson, J. Sundstrom, L. Lind, U. Riserus, A. Larsson, S. Basu, and J. Arnlov Low-grade albuminuria and the incidence of heart failure in a community-based cohort of elderly men Eur. Heart J., July 2, 2007; 28(14): 1739 - 1745. [Abstract] [Full Text] [PDF]

				E. Ingelsson, J. Sundstrom, J. Arnlov, B. Zethelius, and L. Lind Insulin Resistance and Risk of Congestive Heart Failure JAMA, July 20, 2005; 294(3): 334 - 341. [Abstract] [Full Text] [PDF]

				M. R. Carnethon, S. P. Fortmann, L. Palaniappan, B. B. Duncan, M. I. Schmidt, and L. E. Chambless Risk Factors for Progression to Incident Hyperinsulinemia: The Atherosclerosis Risk in Communities Study, 1987-1998 Am. J. Epidemiol., December 1, 2003; 158(11): 1058 - 1067. [Abstract] [Full Text] [PDF]

				U. Riserus, P. Arner, K. Brismar, and B. Vessby Treatment With Dietary trans10cis12 Conjugated Linoleic Acid Causes Isomer-Specific Insulin Resistance in Obese Men With the Metabolic Syndrome Diabetes Care, September 1, 2002; 25(9): 1516 - 1521. [Abstract] [Full Text] [PDF]

				F. de Beer, A. F.H. Stalenhoef, N. Hoogerbrugge, J. J.P. Kastelein, J. A. Gevers Leuven, C. M. van Duijn, L. M. Havekes, and A. H.M. Smelt Expression of Type III Hyperlipoproteinemia in Apolipoprotein E2 (Arg158->Cys) Homozygotes Is Associated With Hyperinsulinemia Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 294 - 299. [Abstract] [Full Text] [PDF]

				R. Frénais, H. Nazih, K. Ouguerram, C. Maugeais, Y. Zaïr, J. M. Bard, B. Charbonnel, T. Magot, and M. Krempf In Vivo Evidence for the Role of Lipoprotein Lipase Activity in the Regulation of Apolipoprotein AI Metabolism: A Kinetic Study in Control Subjects and Patients with Type II Diabetes Mellitus J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1962 - 1967. [Abstract] [Full Text]

				L. Hansen, B. Zethelius, L. Berglund, R. Reneland, T. Hansen, C. Berne, H. Lithell, B. A. Hemmings, and O. Pedersen In Vitro and In Vivo Studies of a Naturally Occurring Variant of the Human p85{alpha} Regulatory Subunit of the Phosphoinositide 3-Kinase: Inhibition of Protein Kinase B and Relationships With Type 2 Diabetes, Insulin Secretion, Glucose Disappearance Constant, and Insulin Sensitivity Diabetes, March 1, 2001; 50(3): 690 - 693. [Abstract] [Full Text]

				N. Matsuoka, Y. Ogawa, H. Masuzaki, K. Ebihara, M. Aizawa-Abe, N. Satoh, E. Ishikawa, Y. Fujisawa, A. Kosaki, K. Yamada, et al. Decreased triglyceride-rich lipoproteins in transgenic skinny mice overexpressing leptin Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E334 - E339. [Abstract] [Full Text] [PDF]

				J. Hulthe, L. Bokemark, J. Wikstrand, and B. Fagerberg The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis : The Atherosclerosis and Insulin Resistance (AIR) Study Arterioscler Thromb Vasc Biol, September 1, 2000; 20(9): 2140 - 2147. [Abstract] [Full Text] [PDF]

				J. Pihlajamaki, L. Karjalainen, P. Karhapaa, I. Vauhkonen, M.-R. Taskinen, S. S. Deeb, and M. Laakso G-250A Substitution in Promoter of Hepatic Lipase Gene Is Associated With Dyslipidemia and Insulin Resistance in Healthy Control Subjects and in Members of Families With Familial Combined Hyperlipidemia Arterioscler Thromb Vasc Biol, July 1, 2000; 20(7): 1789 - 1795. [Abstract] [Full Text] [PDF]

				J.-A. SIMONEAU, JACQUES. H. VEERKAMP, L. P. TURCOTTE, and D. E. KELLEY Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss FASEB J, November 1, 1999; 13(14): 2051 - 2060. [Abstract] [Full Text]

				H. E. Henderson, J. J. P. Kastelein, A. H. Zwinderman, E. Gagné, J. W. Jukema, P. W. A. Reymer, B. E. Groenemeyer, K. I. Lie, A. V. G. Bruschke, M. R. Hayden, et al. Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins J. Lipid Res., April 1, 1999; 40(4): 735 - 743. [Abstract] [Full Text]

				T. Rönnemaa, J. Marniemi, M. J. Savolainen, Y. A. Kesäniemi, C. Ehnholm, C. Bouchard, and M. Koskenvuo Serum Lipids, Lipoproteins, and Lipid Metabolizing Enzymes in Identical Twins Discordant for Obesity J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2792 - 2799. [Abstract] [Full Text]

				J. Nilsson, S. Jovinge, A. Niemann, R. Reneland, and H. Lithell Relation Between Plasma Tumor Necrosis Factor-{alpha} and Insulin Sensitivity in Elderly Men With Non–Insulin-Dependent Diabetes Mellitus Arterioscler Thromb Vasc Biol, August 1, 1998; 18(8): 1199 - 1202. [Abstract] [Full Text] [PDF]

				L. Nie, J. Wang, L. T. Clark, A. Tang, G. L. Vega, S. M. Grundy, and J. C. Cohen Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity J. Lipid Res., May 1, 1998; 39(5): 1127 - 1130. [Abstract] [Full Text] [PDF]

				G. Shepherd, M. C. Cam, N. Sambandam, M. A. Abrahani, and B. Rodrigues Streptozotocin-Induced Diabetes Enhances Cardiac Heparin-Releasable Lipoprotein Lipase Activity in Spontaneously Hypertensive Rats Hypertension, March 1, 1998; 31(3): 878 - 884. [Abstract] [Full Text] [PDF]

				L. Byberg, A. Siegbahn, L. Berglund, P. McKeigue, R. Reneland, and H. Lithell Plasminogen Activator Inhibitor-1 Activity Is Independently Related to Both Insulin Sensitivity and Serum Triglycerides in 70-Year-Old Men Arterioscler Thromb Vasc Biol, February 1, 1998; 18(2): 258 - 264. [Abstract] [Full Text] [PDF]

				K. A. S. Al-Shoumer, K. H. Cox, C. L. Hughes, W. Richmond, and D. G. Johnston Fasting and Postprandial Lipid Abnormalities in Hypopituitary Women Receiving Conventional Replacement Therapy J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2653 - 2659. [Abstract] [Full Text] [PDF]

				J. Jeppesen, C. B. Hollenbeck, M.-Y. Zhou, A. M. Coulston, C. Jones, Y.-D. I. Chen, and G. M. Reaven Relation Between Insulin Resistance, Hyperinsulinemia, Postheparin Plasma Lipoprotein Lipase Activity, and Postprandial Lipemia Arterioscler Thromb Vasc Biol, March 1, 1995; 15(3): 320 - 324. [Abstract] [Full Text]